A personalised cell therapy based on tumour-infiltrating lymphocyte (TIL) cells has been shown to be more effective at improving progression-free survival than Bristol-Myers Squibb's immunotherapy ...

Endocrine Today - Find clinical endocrinology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles from the #1 online source for ...